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The current study was designed to evaluate the renoprotective effect of hydro-alcoholic
extract of Caralluma fimbriata (CFE) against high-fat diet-induced oxidative stress in Wis-
tar rats. Male Wistar rats were randomly divided into five groups: control (C), control
treated with CFE (C þ CFE), high-fat diet fed (HFD), high-fat diet fed treated with CFE
(HFD þ CFE), and high-fat diet fed treated with metformin (HFD þ metformin). CFE was
orally administered (200 mg/kg body weight) to Groups C þ CFE and HFD þ CFE rats for
90 days. Renal functional markers such as, urea, uric acid, and creatinine levels in plasma
were quantified during the experimental period. At the end of the experimental period,
activities of transaminases and oxidative stress markers, i.e., reduced glutathione (GSH),
lipid peroxidation, protein oxidation, and activities of antioxidant enzymes were assayed
in renal tissue. Coadministration of CFE along with HF-diet in Group HFD þ CFE prevented
the rise in the levels of plasma urea, uric acid, and creatinine, and elevated activities of
renal transaminases with decreased protein content of Group HFD (p < 0.05). Establishment
of oxidative stress in Group HFD, as evident from elevated lipid peroxidation, protein
oxidation levels with depleted levels of GSH, and decreased activities of GSH dependent
and independent antioxidant enzymes, was prevented in Groups HFD þ CFE and
HFD þ metformin rats. Further, there were no deviations in the studied parameters but
there was improved antioxidant status of Group C þ CFE from Group C which revealed the
nontoxic nature of CFE even under chronic treatment. Thus, CFE treatment effectively
alleviated the HF-diet induced renal damage. Hence, this plant could be used as an adju-
vant therapy for the prevention and/or management of HF-diet induced renal damage.
Copyright © 2016, Food and Drug Administration, Taiwan. Published by Elsevier Taiwan
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gmail.com (S. Desireddy
ministration, Taiwan. Publ
.org/licenses/by-nc-nd/4.0/araya University, Anantapur 515003, Andhra Pradesh, India.
).
ished by Elsevier Taiwan LLC. This is an open access article under the
).
j o u r n a l o f f o o d and d ru g an a l y s i s 2 4 ( 2 0 1 6 ) 5 8 6e5 9 3 5871. Introduction
Obesity is associated with multiple conditions that are known
to compromise renal function, including insulin resistance,
hyperglycemia, hyperleptinemia, hypertension, dyslipidemia,
and metabolic syndrome which can independently have
detrimental effects on renal function [1]. Further, obesity-
associated insulin resistance is a major risk factor for type 2
diabetes mellitus (DM) and associated long term complica-
tions in DM including diabetic nephropathy. Increasing rates
of obesity may be due to easily accessible and palatable diets.
Unchecked body weight (BW) due to high appetite is also
known as a major cause of obesity. Renal abnormalities are
evident from increased BW, fat accumulation, and glomerular
sclerosis with consumption of high fat (HF) diet [2]. Nutritional
or dietary oxidative stress denotes disturbance of the redox
state resulting from excess oxidative load or from inadequate
nutrient supply favoring pro-oxidant reactions. Postprandial
increases of lipid and carbohydrate levels lead to increased
oxidative stress and lipid hydroperoxides present in the diet
which are absorbed, contributing to the pro-oxidant load [3].
In obesity, oxidized low density lipoprotein levels are
increased which have been shown to stimulate monocyte
adhesion to the glomerular injury [4]. However, most of these
and other conditions resulting in kidney injury are associated
with oxidative stress. Hence, oxidative stress is one of the
most important factors associated with kidney injury [5].
Clinical trials suggest that there is no effective treatment for
obesity/diabetes-induced nephropathy and hence efforts
have been focused on traditional herbalmedicine to find novel
therapeutic agents for the treatment of nephropathy [6].
Recently, herbs and/or natural products have been high-
lighted as alternatives to the current management of diabetic
nephropathy [7].
Caralluma fimbriata (Family: Apocynaceae; CFE), an edible
succulent, is distributed throughout theworld including India.
It is listed in Indian Materia Medica as a vegetable, famine
food, appetite suppressant, and thirst quencher. The stan-
dardized extract of this plant is marketed under the trade
name GensSlim for management of obesity and BW [8]. In
addition, it has several phytotherapeutic properties. Our
earlier studies showed the beneficial effects of C. fimbriata
against HF diet-induced insulin resistance in Wistar rats [9].
Metformin, a biguanide drug, is widely used for the treat-
ment of type 2 DM. It is also reported to possess antioxidant
properties [10]. Recently, much attention has also been
focused on the possible protective role of metformin in dia-
betic kidney diseases. With this background the present work
is planned to investigate the renoprotective effect of C. fim-
briata in comparison with metformin on the progression of
HF-diet induced oxidative stress in Wistar rats.2. Methods
2.1. Chemicals
Pyrogallol and 1-chloro-2, 4-dinitrobenzene (CDNB) were ob-
tained from SISCO Research Laboratories (P) Ltd., Mumbai,India. All other chemicals and solvents of analytical grade
were procured from Sigma Chemical Co., St. Louis, MO, USA.
2.2. Plant extract
Hydro-alcoholic extract of CFE (brown, dry powder with Batch
Number CFE/10011) whole herb was a gift from Green-Chem
Herbal Extracts and Formulations, Bangalore, Karnataka,
India. The procedure followed by the firm for the preparation
of the extract is as follows: the aerial parts of the plant CFwere
collected, dried in shade, and sized by a crusher to extract
material. One hundred grams of the plant material was
extractedwith 40% aqueous alcohol (40 parts of alcohol and 60
parts of water). Twelve kilograms of the dried herb obtained
from 100 kg of the fresh plant gave a final yield of 1 kg of
extract having 25% pregnane glycosides. The extract was
dissolved in distilled water prior to use.
2.3. Qualitative phytochemical analysis
Phytochemical analysis of CFEwas carried out to ascertain the
qualitative composition of secondary metabolites such as al-
kaloids, anthocyanins, anthocyanidins, anthracene glyco-
sides, antraquinones, aucubins, carboxylic acids, catecholic
compounds, coumarins, fatty acids, flavonoids, gallic-tannins,
phenols, saponins, steroids, and triterpenoids by employing
coloration and precipitation test [11].
2.4. Quantitative estimation of total phenols, flavonoids,
and saponins
2.4.1. Total phenol content
The total phenolic compound of CFE was assessed using
FolineCiocalteau phenol reagent method described by
Singleton et al [12]. Briefly, 1.0 mL of the extract (1.25 mg) was
mixedwith 2.5mL of 10% FolineCiocalteau reagent and 2.5mL
of 7.5% sodium carbonate. The contents were thoroughly
mixed and allowed to stand for 30 minutes. The absorbance
was read at 750 nm in a spectrophotometer. The total phenol
content was expressed as gallic acid equivalents in milligram
per gram of the extract using a standard curve generated with
gallic acid (range, 50e500 mg).
2.4.2. Flavonoid estimation
The flavonoid content of CFE was determined using
aluminum chloride colorimetric method described by Chang
et al [13]. Briefly, 0.5mL of CFE (2.5mg) wasmixedwith 3mL of
95% methanol, 0.1 mL of 10% (weight/volume) aluminum
chloride, 0.1 mL of 1M potassium acetate, and 2.8 mL of
distilled water. The reaction mixture was allowed to stand at
room temperature for 30 minutes and absorbance was
measured at 415 nm against a blank sample. A calibration
curve was prepared using quercetin in methanol (range,
10e100 mg). The flavonoid content was expressed as quercetin
equivalents in milligram per gram of the extract.
2.4.3. Saponins content
The total saponins content of CFE was determined using the
method of Hiai et al [14]. A freeze-dried CFE was dissolved in
80% aqueous methanol. To 250 mL of dissolved saponins,
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and 2.5 mL of 72% (volume/volume) sulfuric acid were added
slowly by the inner side of thewall of the test tube,mixed, and
kept in a water bath at 66C for 10 minutes and then cooled in
ice cold water for 3e4 minutes before the absorbance was
measured at 544 nm against a reagent blank. The total
saponin content was expressed as diosgenin equivalents in
milligram per gram of the extract using a standard curve
generated with diosgenin (range, 25e500 mg).
2.5. Animals and HF-diet
Male Wistar rats (170e190 g) used for the present study were
procured from Sri Raghavendra Enterprises, Bangalore, India.
The animals were acclimatized for 7 days in our animal house
(Registered Number 470/01/a/CPCSEA) before dietary manip-
ulation. They were housed two per cage in an air-conditioned
room (22 ± 2C) with 12-hour light/dark cycle and had free
access to a standard pellet diet and water. All the procedures
were performed in accordance with the Institutional Animal
Ethics Committee (Sri Krishnadevaraya University, Anantha-
pur, Andhra Pradesh, India). The animals were fed ad libitum
with a balanced animal pellet diet.
HF diet was procured from the National Institute of
Nutrition, Hyderabad, Andhra Pradesh, India. According to
Diet Induced Obesity Diets, New Brunswick, NJ, USA, specifi-
cations for HF diet (D12492) wherein lard was used as the fat
source and the diet contained approximately 60 kcal% of fat,
20 kcal% of protein, and 20 kcal% of carbohydrate. Briefly, 1 kg
of the diet composed of casein, 200 g; sucrose, 68.8 g; malto
dextrin-10, 125 g; cellulose, 50 g; soybean oil, 25 g; lard, 245 g;
L-cystine, 3 g; mineral mix (S10026), 10 g; di-calcium phos-
phate, 13 g; calcium carbonate, 5.5 g; potassium citrate mono-
hydrate, 16.5 g; vitamin mix (V10001), and 10 g; choline
bitartarate, 2 g.
2.6. Experimental design
The experimental rats were divided into five groups, each
comprising eight rats: control rats (C); control rats treatedwith
CFE (200 mg/kg BW/d) in distilled water orally by gastric
intubation for 90 days (C þ CFE); HF-diet fed rats (HFD); HF diet
fed rats treated with CFE (200 mg/kg BW/d) in distilled water
orally by gastric intubation for 90 days (HFD þ CFE); and HF
diet fed rats treated with metformin (20 mg/kg BW/d) in
distilled water orally for 90 days (HFD þ Met). Rats from
Groups HFD, HFD þ CFE, and HFD þMet were fed with HF diet
for 90 days and rats from Group C and C þ CFE were fed a
normal pellet diet. Rats from Groups C and HFD received
distilled water as a vehicle control.
2.7. Sample collection
During the experimental period at 30-day intervals, blood was
collected from 12-hour fasted rats with a capillary tube from
the retino-orbital plexus in fresh vials containing EDTA
(10 mg/mL) and centrifuged at 8000g for 5 minutes. Plasma
was separated and used for the estimation of creatinine, urea,
and uric acid. At the end of the experimental period, i.e.,
90 days, the animals were fasted overnight and sacrificed bycervical dislocation. The kidneys were excised into ice cold
saline, thoroughly rinsed, and the weight was recorded.
2.8. Renal functional markers
Renal functional markers in plasma, i.e., urea, uric acid, and
creatinine were quantified using commercial kits (Excel
Diagnostic kits, Hyderabad, India). Ten percent renal homog-
enate prepared in 0.1M Tris-HCl buffer (pH 7.4) was centri-
fuged at 18,514g for 45 minutes in the Laboratory centrifuge
5804 R model (Eppendorf India Ltd), rotor number 14030. The
clear supernatant obtainedwas used for the assay of the renal
transaminases, i.e., glutamate oxaloacetate transaminase
(GOT) and glutamate pyruvate transaminase (GPT) following
the method of Reitman and Frankel [15].
2.9. Oxidative stress markers
Ten-percent tissue homogenate prepared in 0.15M KCl at 4C
was used for the estimation of lipid peroxidation (LPO), pro-
tein oxidation (PO), and reduced glutathione (GSH). LPO in the
kidney was estimated colorimetrically by measuring the thi-
obarbituric acid reactive substances using themethod of Utley
et al [16]. The extent of LPO was expressed as nmoles of
malondialdehyde formed/g tissue, using a molar extinction
coefficient of malondialdehyde as 1.56  105M/cm. GSH was
determined according to the method of Ellman [17] using 5,5-
dithiobis (2-nitrobenzoic acid), which readily gets reduced by
sulfhydryl compounds forming a highly colored anion having
a maximum absorbance at 412 nm. Protein carbonyl content
was measured by forming hydrazone derivatives using 2, 4-
dinitrophenylhydrazine which were quantified spectropho-
tometrically at 370 nm according to themethod of Levine et al
[18]. The protein concentration in the tissue homogenate and
supernatant were measured by themethod of Lowry et al [19].
2.10. Antioxidant enzyme assays
Ten-percent tissue homogenate in 0.15M KCl was prepared
using a PottereElvehjem (Sigma-Aldrich, India) homogenizer
at 4C and centrifuged in the cold (4C) at 18,514g for 45 mi-
nutes. The clear supernatant was used for assay of antioxi-
dant enzymes. Glutathione peroxidase (GPx) was assayed
using themethod of Rotruck et al [20]. A known amount of the
enzymewas allowed to react with H2O2 in the presence of GSH
for a specified time period and the remaining GSH was
measured using the method of Ellman [17]. The activity was
expressed as mg of GSH consumed/min/mg protein.
Glutathione-s-transferase (GST) activity was assayed by
monitoring the increase in the absorbance at 340 nm using 1-
chloro-2, 4-dinitrobenzene (CDNB) as a substrate according to
the method of Habig et al [21]. The activity was expressed as
mmoles of CDNB-GSH conjugate formed/min/mg protein using
millimolar extinction coefficient of CDNB-GSH conjugate as
9.6. Glutathione reductase (GR) activity was assayed by
following the oxidation of nicotinamide adenine dinucleotide
phosphate (NADPH) spectrophotometrically at 340 nm ac-
cording to the method of Pinto and Bartley [22]. The activity
was expressed as mmoles of NADPH oxidized/min/mg protein
by using millimolar extinction coefficient of NADPH as 6.22.
Table 2 e Quantitative phytochemicals profile of
Caralluma fimbriata.
Total
polyphenolic
compounds
(mg gallic
acid
equivalents/g
extract)
Flavonoids
(mg quercetin
equivalents/g
extract)
Saponins
(mg diosgenin
equivalents/g
extract)
60.0 ± 0.28 2.2 ± 0.10 6.2 ± 0.20
Data are presented as expressed as mean ± standard error of the
mean (n ¼ 3).
Table 3 e Absolute and relative kidney weight in five
experimental groups.
Groups Kidney tissue weight
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modified procedure adopted by Soon and Tan [23], based on its
ability to inhibit the oxidation of pyrogallol. Change in
absorbance was monitored at 420 nm for 5 minutes and the
activity was expressed as the amount of enzyme required to
inhibit the oxidation of pyrogallol by 50% which was equal to
one unit. The activity was expressed as units/min/mg of
protein. Catalase (CAT) activity was assayed by following the
decomposition of H2O2 spectrophotometrically at 240 nm ac-
cording to themethod of Beers and Sizer [24]. The activity was
expressed as mmoles of H2O2 decomposed/min/mg protein.
2.11. Statistical analysis
The results were expressed as mean ± standard error. Data
were analyzed for significant difference using Duncan's Mul-
tiple Range test (p < 0.05) using SPSS/PC statistical program
(version 13.0 for Windows; SPSS Inc., Chicago, IL, USA) [25].Absolute (g) Relative (g/100 g body weight)
Control 2.04 ± 0.04a 0.53 ± 0.02a
C þ CFE 2.00 ± 0.03a 0.58 ± 0.01b
HFD 2.27 ± 0.07b 0.63 ± 0.02c
HFD þ CFE 1.96 ± 0.02a 0.54 ± 0.01a
HFD þ Met 1.96 ± 0.02a 0.57 ± 0.01b
Data are presented as mean ± standard error of the mean (n ¼ 8
animals). Values with different superscripts within the column are
significantly different at p < 0.05 (Duncan's multiple range test).3. Results
3.1. Phytochemical profile of CFE
The phytochemical screening of hydro-alcoholic extract of CF
whole plant revealed the presence of alkaloids, anthocyanins,
carboxylic acids, coumarins, flavonoids, gallic-tannins, phe-
nols, saponins, and steroids indicating the presence of phar-
macologically important phytochemicals (Table 1) whereas
quantitative phytochemical analysis of CFE (Table 2) showed
an appreciable amount of polyphenolic compounds (60 mg
gallic acid equivalents/g extract) followed by saponins (6.2 mg
diosgenin equivalents/g extract) and flavonoids (2.2 mg
quercetin equivalents/g extract).
3.2. Absolute and relative kidney weight
As shown in Table 3, Group HFD showed significantly higher
absolute and relative weight of kidney (11.3% and 18.9%,
respectively) compared with Group C whereas Groups
HFD þ CFE and HFD þ Met showed ameliorating effects of
respective treatments against HF diet-induced gain in abso-
lute and relative kidney weight.
3.3. Renal functional markers and transaminases
Plasma concentrations of urea, uric acid, and creatinine at
0 days, 30 days, 60 days, and 90 days of the experimentalTable 1 e Qualitative phytochemical profile of Caralluma fimbr
Phytochemicals Presence (þ)/absence ()
Alkaloids þ
Anthocyanins þ
Anthocyanidins e
Anthracene glycosides e
Antraquinones e
Aucubins e
Carboxylic acids þ
Catecholic compounds eperiod in five groups are presented in Table 4. In comparison
with Group C, Group HFD showed increased levels of urea
(34.6%), uric acid (152.5%), and creatinine (50.0%) at 90 days of
the experimental period. The Groups HFD þ CFE and
HFD þ Met showed a significant reduction in urea (31.9%/
33.1%), uric acid (46.9%/48.4%), and creatinine (40.7%/41.7%)
compared with Group HFD by the end of the experimental
period respectively. CFE/Met coadministration along with HF
diet in Groups HFD þ CFE and HFD þ Met ameliorated the HF
diet induced hike in the renal GOT (29.6%) and GPT (28.4%)
comparedwith Group C. No significant variationwas observed
in the activities of renal transaminases between Groups C and
C þ CFE (Table 5).3.4. Renal oxidative stress markers and antioxidants
Figure 1 shows the renal oxidative stress markers. Group HFD
showed significantly higher levels of LPO (149.7%) and PO
(16.3%) and low levels of renal GSH (38.1%) as compared withiata.
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Table 5 e Effect of Caralluma fimbriata (CFE)/metformin
(Met) on the activities of renal transaminases and protein
content in High-fat (HF) diet fed Wistar rats.
Parameters GOT
(mg of pyruvate
formed/min/mg
protein)
GPT (mg of
pyruvate
formed/min/mg
protein)
Protein
(mg/g
tissue)
Control 1.62 ± 0.15a 0.81 ± 0.15a 4.46 ± 0.025a
C þ CFE 1.58 ± 0.18a 0.83 ± 0.12a 4.31 ± 0.023b
HFD 2.10 ± 0.28b 1.04 ± 0.23c 4.83 ± 0.043c
HFD þ CFE 1.77 ± 0.15c 0.94 ± 0.12b 4.44 ± 0.030a
HFD þ Met 1.71 ± 0.18d 0.91 ± 0.13b 4.43 ± 0.032a
Data are presented as mean ± standard error of the mean values of
eight rats per group. Means in the same column not sharing a
common superscript are significantly different (p < 0.05).
C ¼ control rats; C þ CFE, control rats treated with Caralluma fim-
briata; HFD ¼ high-fat diet fed rats; HFD þ CFE ¼ high-fat diet fed
rats treated with CFE; HFD þ Met ¼ high-fat diet fed rats treated
with metformin.
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Groups HFD þ CFE and HFD þ Met for 90 days prevented the
increased LPO and PO and decreased GSH levels in kidney.
Table 6 shows the activities of antioxidant enzymes in
kidney of the five experimental groups. The activities of GPx,
GR, GST, superoxide dismutase, and CAT were significantly
lowered (23.7%, 15.2%, 40.7%, 24.3%, and 28.3%, respectively)
in Group HFD rats compared with Group C. Coadministration
of CFE/Met along with HF diet in Groups HFD þ CFE and
HFD þ Met for 90 days prevented HF diet-induced decline in
the activities of enzymes in kidney. However, CFE adminis-
tration to control rats (Group C þ CFE) caused a slight increase
in the activities of these antioxidant enzymes.4. Discussion
The present study revealed that CFE contains pharmacologi-
cally important phytochemicals. Numerous epidemiological
studies suggest that herbs/diets rich in phytochemicals and
antioxidants execute a protective role in health and disease.
Quantitative phytochemical analysis of CFE (Table 1) showed
an appreciable amount of polyphenolic compounds followed
by saponins and flavonoids. Pregnane glycosides, flavanone
glycosides, megastigmane glycosides, bitter principles, sapo-
nins, and various other flavonoids are reported as the key
phytochemical ingredients in Caralluma species [26]. Poly-
phenols are the major plant compounds with antioxidant
activity [27]. Saponins have been reported to possess a wide
range of biological activities due to its antioxidant activity.
Flavonoids are reported to be beneficial against obesity and
diabetes [28]. The presence of these phytochemicals in CFE
and synergism among these compounds may be the most
likely option for the protective effect of CFE against HF diet-
induced metabolic alterations in the present study.
Lifestyle factors and diet play a key role in the development
of kidney disease in several stages including progress of
obesity and metabolic syndrome and occurrence of obesity-
related glomerulopathy. These are associated with increased
Figure 1 e (A) Lipid peroxidation (LPO): (B) reduced glutathione (GSH); and (C) protein oxidation (PO) in renal tissue of all
experimental groups of rats. Values are mean ± standard error of the mean (n ¼ 8 animals in each group). Means in the
same column not sharing a common superscript are significantly different (p < 0.05). C ¼ control rats; C þ CFE, control rats
treated with Caralluma fimbriata; HFD ¼ high-fat diet fed rats; HFD þ CFE ¼ high-fat diet fed rats treated with CFE;
HFD þ Met ¼ high-fat diet fed rats treated with metformin; MDA ¼ methylenedioxyamphetamine.
Table 6 e Effect of Caralluma fimbriata (CFE)/metformin (Met) on the activities of antioxidant enzymes in high-fat (HF) diet
fed Wistar rats.
Parameters Control C þ CFE HFD HFD þ CFE HFD þ Met
GPx (mg of GSH consumed/min/mg protein) 5.27 ± 0.09a 5.83 ± 0.06b 4.02 ± 0.08c 5.53 ± 0.03d 5.01 ± 0.06e
GR (mmol NADPH oxidized/min/mg protein) 32.16 ± 0.37a 32.73 ± 0.32a 27.28 ± 0.36b 32.79 ± 0.29a 32.78 ± 0.22a
GST (mmol CDNB-GSH conjugate formed/min/mg protein) 71.92 ± 0.11a 71.13 ± 0.31a 42.66 ± 0.31b 71.19 ± 0.20a 71.72 ± 0.32a
SOD (U/mg protein) 21.42 ± 0.26a 24.53 ± 0.20b 16.22 ± 0.29c 21.26 ± 0.22a 22.06 ± 0.18d
CAT (mmol H2O2 consumed/min/mg protein) 34.54 ± 0.37
a 35.76 ± 0.13b 24.75 ± 0.24c 31.99 ± 0.42d 32.85 ± 0.21d
Data are presented as mean ± standard deviation values of eight rats per group. Means in the same row not sharing a common superscript are
significantly different (p < 0.05).
C ¼ control rats; CAT ¼ catalase; C þ CFE, control rats treated with Caralluma fimbriata; GPx ¼ glutathione peroxidase; GR ¼ glutathione
reductase; GST ¼ glutathione-s-transferase; HFD ¼ high-fat diet fed rats; HFD þ CFE¼ high-fat diet fed rats treated with CFE; HFD þMet ¼ high-
fat diet fed rats treated with metformin; SOD ¼ superoxide dismutase.
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inflammation and deterioration of renal function [29]. In the
present study we found that HFD caused significant elevation
of plasma urea, creatinine, and uric acid by chronic feeding of
a HF diet is an indication of defective kidney function in Group
HFD rats which are in agreement with earlier reports [30].
Whereas studies on hypercalorie/cafeteria diet fed obese rats
showed no change in serum urea with a significant rise in
creatinine and uric acid levels [31]. Decreased renal protein
content with enhanced activities of tissue GOT and GPT
observed in Group HFD rats indicates enhanced catabolism of
proteins ultimately resulting in increased production of ureain these animals. In addition to this, decreased renal clearance
due to impaired renal function under HF diet fed conditions
might have aggravated the situation. Coadministration of
CFE/Met along with HF diet has given protection from HF diet-
induced kidney dysfunction as it normalized the increased
levels of plasma urea, creatinine, and renal transaminases in
Groups HFDþ CFE andHFDþMet. These protective properties
of the extract may be due to its ameliorative activity on
metabolic alterations observed under HF diet fed conditions
and may also be because the plant is very rich in phyto-
chemical ingredients with antioxidant properties [32]. A
similar observation of the renoprotective role of CFE was
j o u rn a l o f f o o d a nd d r u g an a l y s i s 2 4 ( 2 0 1 6 ) 5 8 6e5 9 3592reported against increased levels of serum creatinine and uric
acid in hypercalorie/cafeteria diet fed rats [33].
HF diet-induced oxidative stress as evidenced by elevated
renal LPO, PO, with a decreased GSH level in Group HFD rats is
in agreement with an earlier report [34]. Kume et al [35] re-
ported that renal injury observed under HF diet fed conditions
might be due to HF diet-induced alteration of renal lipid
metabolism by an imbalance between lipogenesis and lipol-
ysis along with systemic metabolic abnormalities and subse-
quent renal lipid accumulation and LPO. Damaged renal tissue
acts as sources of reactive oxygen species (ROS) and activates
the process of LPO. Previous studies strongly suggest that
oxidative stress induced by HF diet enhances lipid peroxida-
tion and diminishes the activities of antioxidant enzymes [36].
GSH represents the first line of defense against free radicals
and is also responsible for the maintenance of protein thiols
and acts as a substrate for GPx and GST. GPx activity is
considered to symbolize the initial protective response
required for adjusting the H2O2 concentration under physio-
logical condition as well as after oxidative insult. Further-
more, it has been postulated that high intake of dietary fat
enhances ROS overproduction. ROS themselves can reduce
the activity of antioxidant enzymes such as CAT and GPx [37].
A significant decrease in the level of GSH in Group HFD rats
could be the result of decreased synthesis or increased
degradation/utilization of GSH by increased oxidative stress
and decreased regeneration as evident from the lower activity
of GR.
The antioxidant potential of CFE against HF diet-induced
oxidative stress is evident from lower levels of PO, LPO,
higher GSH levels, and increased activities of antioxidant
enzymes seen in Group HFD þ CFE when compared with
Group HFD. A significant increase in the GSH content in
kidneys of CFE-treated HF diet-fed rats indicates that CFE
treatment activated the compensatory mechanism against
the oxidative stress, which might have either increased the
biosynthesis of GSH or lowered the utilization of GSH due to
decreased oxidative stress or both. Explanations of possible
mechanisms underlying the antioxidant potential of a drug
include the prevention of GSH depletion and destruction of
free radicals due to its rich antioxidant phytochemical pro-
file. The antioxidant potential of this plant against oxidative
stress in the liver has been well documented [9]. Hence, ex-
tracts from Caralluma species are the object of increasing
interest for nutraceutical companies [38]. The significant
attenuation of oxidative stress in Group HFD þ Met indicates
a protective role of metformin against HF diet-induced
oxidative stress in kidney. These findings are in agreement
with earlier reports in diabetic rats [39]. Various in-
vestigations show that Met decreases intracellular ROS and
protects tubular injury by restoring the biochemical alter-
ations and regulation of oxidative stress on renal tubules.
Therefore Met may exert some of its beneficial effects by
improvement of renal oxidative stress under HF diet fed
conditions. Thus, we hypothesize that the possible explana-
tion for reducing renal injury following the consumption of
CFE can be a useful add-on therapy to curtail oxidative stress
in HF diet-induced Wistar rats. Similar to CFE treatment, Met
treated HF diet fed rats also showed protection from HF diet
induced oxidative stress.5. Conclusion
In view of these findings, it is possible to conclude that HF diet
feeding results in pronounced oxidative stress leading to
kidney malfunctioning which may lead to renal damage. CFE/
Met treatment significantly ameliorated the renal dysfunction
and oxidative stress observed under HF diet-fed conditions.
Based on the results of the present and our earlier study [9], it
is suggested that the renoprotective effect of CFE may be
attributed to its antiobesity properties like controlling BW and
obesity-associated metabolic disorders, i.e., hyperglycemia,
insulin resistance, hypertriglyceridemia, and hyperleptinemia
along with its antioxidant potential. Thus, hydro-alcoholic
extract of CF would seem useful as an adjuvant for the pre-
vention and/or management of oxidative stress in kidney.Conflicts of interest
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